Human Genome Epidemiology Literature Finder
Pharmacogenomics
Records 1 - 30 (of 487 Records) |
Query Trace: Cetuximab[original query] |
---|
The Potential for Selective Cyclin-Dependent Kinase 4/6 Inhibition in the Therapy for Head and Neck Squamous Cell Carcinoma. Cancer journal (Sudbury, Mass.) 2022 9 28 (5): 377-380. Adkins Douglas, Ley Jessica, Cohen Jared, Oppelt Pet |
Genetic variants involved in the cGAS-STING pathway predict outcome in patients with metastatic colorectal cancer: Data from FIRE-3 and TRIBE trials. European journal of cancer (Oxford, England : 1990) 2022 Jun 172 22-30. Wang Jingyuan, Xiao Yi, Loupakis Fotios, Stintzing Sebastian, Yang Yan, Arai Hiroyuki, Battaglin Francesca, Kawanishi Natsuko, Jayachandran Priya, Soni Shivani, Zhang Wu, Mancao Christoph, Cremolini Chiara, Liu Tianshu, Heinemann Volker, Falcone Alfredo, Shen Lin, Millstein Joshua, Lenz Heinz-Jos |
Germline Polymorphisms in Genes Involved in the Antioxidant System Predict the Efficacy of Cetuximab in Metastatic Colorectal Cancer Patients Enrolled in FIRE-3 Trial. Clinical colorectal cancer 2022 May . Arai Hiroyuki, Millstein Joshua, Yang Yan, Stintzing Sebastian, Wang Jingyuan, Battaglin Francesca, Kawanishi Natsuko, Jayachandran Priya, Soni Shivani, Zhang Wu, Heinemann Volker, Lenz Heinz-Jos |
Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience. ESMO open 2022 6 7 (3): 100506. Boccaccino A, Borelli B, Intini R, Antista M, Bensi M, Rossini D, Passardi A, Tamberi S, Giampieri R, Antonuzzo L, Noto L, Roviello G, Zichi C, Salati M, Puccini A, Noto C, Parisi A, Rihawi K, Persano M, Crespi V, Libertini M, Giordano M, Moretto R, Lonardi S, Cremolini |
EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer. Cancers 2022 5 14 (10): . Cserepes Mihály, Nelh?bel Györgyi A, Meilinger-Dobra Mónika, Herczeg Adrienn, Türk Dóra, Heged?s Zita, Svajda Laura, Rásó Erzsébet, Ladányi Andrea, Csikó Kristóf György, Kenessey István, Szö?r Árpád, Vereb György, Remenár Éva, Tóvári Józs |
Therapeutic impact of determination of RAS mutations in the plasma of patient with colorectal cancer. Gastroenterology and hepatology from bed to bench 2022 5 15 (1): 93-98. Macedo F, Monteiro J, Pereira T Cunha, Monteiro A R, Felix Soares R, Bonito N, Sousa |
The Impact of Sidedness on the Efficacy of Anti-EGFR-Based First-Line Chemotherapy in Advanced Colorectal Cancer Patients in Real-Life Setting-A Nation-Wide Retrospective Analysis (RACER). Cancers 2023 9 15 (17): . Pawe? Micha? Potocki, Rafa? Wi?niowski, Dominik Haus, Zbyszko Chowaniec, Maciej Kozaczka, Magdalena Kustra, Marzenna Samborska-Plewicka, Marcin Szweda, Danuta Starzyczny-S?ota, Magdalena Michalik, Grzegorz S?omian, Aneta Lebiedzi?ska, Natalia Jonak-Olczyk, Natalia ?aszewska-Krai?ska, Krzysztof Adamowicz, Piotr Kolenda, Anna Drosik-Kwa?niewska, Marek Szwiec, Robert Dziura, Justyna Czech, Maria D?browska, Ewa Nowakowska-Zajdel, Ewa Klank-Soko?owska, Kamil Konopka, ?ukasz Kwinta, Jolanta Dobrza?ska, Piotr J Wysoc |
The inherited KRAS-variant as a biomarker of Cetuximab Response in NSCLC. Cancer research communications 2023 9 . Joanne B Weidhaas, Chen Hu, Ritsuko Komaki, Gregory A Masters, George R Blumenschein, Joe Y Chang, Bo Lu, Adam P Dicker, Jeffrey A Bogart, Yolanda I Garces, Samir Narayan, Clifford G Robinson, Vivek S Kavadi, Joel S Greenberger, Christopher D Koprowski, James W Welsh, Elizabeth Gore, Robert M MacRae, Rebecca Paulus, Jeffrey Bradl |
Overall Survival, BRAF, RAS, and MSI Status in Patients Who Underwent Cetuximab After Refractory Chemotherapy for Metastatic Colorectal Cancer. Journal of gastrointestinal cancer 2023 8 . Florinda A Santos, Rui Manuel Reis, Lucas C Barroti, Allan A L Pereira, Marcus M Matsushita, Ana Carolina de Carvalho, José Guilherme Datorre, Gustavo N Berardinelli, Raphael L C Arau |
Lasting response by vertical inhibition with cetuximab and trametinib in KRAS-mutated colorectal cancer patient-derived xenografts. Molecular oncology 2023 8 . Timm M Reissig, Swetlana Ladigan-Badura, Anja Steinberg, Abdelouahid Maghnouj, Ting Li, Berlinda Verdoodt, Sven T Liffers, Michael Pohl, Heiner Wolters, Christian Teschendorf, Richard Viebahn, Jakob Admard, Nicolas Casadei, Andrea Tannapfel, Wolff Schmiegel, Stephan A Hahn, Deepak B Vanga |
Preoperative chemotherapy prior to primary tumour resection for asymptomatic synchronous unresectable colorectal liver-limited metastases: The RECUT multicenter randomised controlled trial. European journal of cancer (Oxford, England : 1990) 2023 7 191 112961. Qi Lin, Kefeng Ding, Ren Zhao, Hao Wang, Ye Wei, Li Ren, Qinghai Ye, Yuehong Cui, Guodong He, Wentao Tang, Qingyang Feng, Dexiang Zhu, Wenju Chang, Xiaoying Wang, Li Liang, Guofeng Zhou, Fei Liang, Feng Ye, Jianwei Wang, Jia Fan, Jianmin |
The BEETS (JACCRO CC-18) trial: an observational and translational study of BRAF-mutated metastatic colorectal cancer. Future oncology (London, England) 2023 7 19 (17): 1165-1174. Chiaki Inagaki, Ryo Matoba, Satoshi Yuki, Manabu Shiozawa, Akihito Tsuji, Eisuke Inoue, Kei Muro, Wataru Ichikawa, Masashi Fujii, Yu Sunaka |
FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAF-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 6 JCO2201420. Sebastian Stintzing, Kathrin Heinrich, David Tougeron, Dominik Paul Modest, Ingo Schwaner, Jan Eucker, Rudolf Pihusch, Martina Stauch, Florian Kaiser, Christoph Kahl, Meinolf Karthaus, Christian Müller, Christof Burkart, Anke Reinacher-Schick, Stefan Kasper-Virchow, Ludwig Fischer von Weikersthal, Beate Krammer-Steiner, Gerald Wolfgang Prager, Julien Taieb, Volker Heinema |
A single-center retrospective analysis of the efficacy and safety of a modified regimen of irinotecan plus S-1 (IRIS) with molecular targeting agents as second-line chemotherapy in Japanese patients with recurrent or nonresectable colorectal cancer. Journal of gastrointestinal oncology 2023 5 14 (2): 663-675. Shigeo Higami, Masaya Mukai, Daiki Yokoyama, Syuji Uda, Rin Abe, Nana Mamuro, Kyoko Kishima, Sayuri Hasegawa, Takayuki Tajima, Eiji Nomura, Hiroyasu Makuuc |
Maintenance therapy with Fluoropyrimidine and cetuximab or bevacizumab after first line FOLFOX-chemotherapy in metastatic colorectal cancer according to RAS or BRAF mutation status. Journal of cancer research and clinical oncology 2023 4 . Kang Sora, Lee Myung-Won, Song Ik-Chan, Lee Hyo-Jin, Yun Hwan-Jung, Jo Deog-Yeon, Kim Jung Sun, Kwon Jung Hye, Kim Ji-Yeon, Lee Kyung-Ha, Ryu Hyew |
Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer. ESMO open 2023 4 8 (3): 101198. G Martini, V Belli, S Napolitano, V Ciaramella, D Ciardiello, A Belli, F Izzo, A Avallone, F Selvaggi, F Menegon Tasselli, W Santaniello, R Franco, I Puig, L Ramirez, I Chicote, F Mancuso, G Caratu, X Serres, R Fasani, J Jimenez, J Ros, I Baraibar, N Mulet, C M Della Corte, T Troiani, A Vivancos, R Dienstmann, E Elez, H G Palmer, J Tabernero, E Martinelli, F Ciardiello, G Argil |
Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the "CARACAS" study. European journal of cancer (Oxford, England : 1990) 2023 2 182 87-97. Prete Alessandra A, Manca Paolo, Messina Marco, Formica Vincenzo, Frassineti Giovanni L, Zampino Maria G, Corsi Domenico C, Orciuolo Corrado, Prisciandaro Michele, Bergamo Francesca, Angerilli Valentina, Scartozzi Mario, Casagrande Mariaelena, Masi Gianluca, Ronzoni Monica, Morano Federica, Vettore Valentina, Salmaso Roberta, Rasola Cosimo, Maddalena Giulia, Del Bianco Paola, Milione Massimo, Cremolini Chiara, Fassan Matteo, Pietrantonio Filippo, Lonardi Sa |
Effects of KMT2D mutation and its exon 39 mutation on the immune microenvironment and drug sensitivity in colorectal adenocarcinoma. Heliyon 2023 2 9 (2): e13629. Liu Chuan, Jin Yuzhi, Zhang Hangyu, Yan Junrong, Guo Yixuan, Bao Xuanwen, Zhao Pe |
Impact of genetic variants involved in the lipid metabolism pathway on progression free survival in patients receiving bevacizumab-based chemotherapy in metastatic colorectal cancer: a retrospective analysis of FIRE-3 and MAVERICC trials. EClinicalMedicine 2023 2 57 101827. Wang Jingyuan, Millstein Joshua, Yang Yan, Stintzing Sebastian, Arai Hiroyuki, Battaglin Francesca, Kawanishi Natsuko, Soni Shivani, Zhang Wu, Mancao Christoph, Cremolini Chiara, Liu Tianshu, Heinemann Volker, Falcone Alfredo, Shen Lin, Lenz Heinz-Jos |
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial. Nature medicine 2023 12 . Jayesh Desai, Guzman Alonso, Se Hyun Kim, Andres Cervantes, Thomas Karasic, Laura Medina, Einat Shacham-Shmueli, Rasha Cosman, Alejandro Falcon, Eelke Gort, Tormod Guren, Erminia Massarelli, Wilson H Miller, Luis Paz-Ares, Hans Prenen, Alessio Amatu, Chiara Cremolini, Tae Won Kim, Victor Moreno, Sai-Hong I Ou, Alessandro Passardi, Adrian Sacher, Armando Santoro, Rafal Stec, Susanna Ulahannan, Kathryn Arbour, Patricia Lorusso, Jia Luo, Manish R Patel, Yoonha Choi, Zhen Shi, Sandhya Mandlekar, Mark T Lin, Stephanie Royer-Joo, Julie Chang, Tomi Jun, Neekesh V Dharia, Jennifer L Schutzman, , Sae-Won H |
Treatment Patterns and Prognosis of Palliative Chemotherapy Combined With Targeting Agents in Patients With Unresectable Metastatic Colorectal Cancer: CHOICE, A Multicenter Longitudinal Observational Study. Anticancer research 2023 12 44 (1): 347-359. Jwa Hoon Kim, Yongjun Cha, Sang Joon Shin, Young Suk Park, Jung Hun Kang, Chan Kim, Sung Hee Lim, Myoung Joo Kang, Jong Gwang Kim, In Gyu Hwang, Jong-Kwon Choi, Seong Hoon Shin, Seok Yun Kang, Sang-Cheol Lee, Seung Taek Lim, Jung Sun Kim, Hei-Cheul Jeung, Myoung Hee Kang, In Sil Choi, Hye Won Ryu, Kyung Hee Lee, Moon Hee Lee, Ji Young Lee, Ji Hyun Park, So-Yeon Jeon, Namsu Lee, Chi-Young Park, Yeul Hong K |
Anti-epidermal growth factor receptor treatment for patients with NeoRAS wild-type metastatic colorectal cancer: a case report of two cases. Therapeutic advances in medical oncology 2023 11 15 17588359231216090. Kazuaki Harada, Satoshi Yuki, Yasuyuki Kawamoto, Takeaki Nakamura, Shiho Kaneko, Koichi Ishida, Naoya Sakamoto, Yoshito Komat |
A Phase I Study of the CDK4/6 Inhibitor, Palbociclib in Combination with Cetuximab and Radiotherapy (IMRT) for Locally Advanced Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 11 . Nuttapong Ngamphaiboon, Poompis Pattaranutaporn, Somthawin Lukerak, Teerada Siripoon, Artit Jinawath, Lalida Arsa, Prapimporn Ch Shantavasinkul, Naphat Taonam, Narumol Trachu, Natini Jinawath, Arpakorn Kositwattanarerk, Thiparom Sananmuang, Chuleeporn Jiarpinitn |
Allelic context of EGFR C797X mutant lung cancer defines four subtypes with heterogeneous genomic landscape and distinct clinical outcomes. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2023 11 . Chang Lu, Xue-Wu Wei, Zhen Wang, Zhen Zhou, Yu-Tao Liu, Di Zheng, Yong He, Zhan-Hong Xie, Yong Li, Yan Zhang, Yi-Chen Zhang, Zi-Jian Huang, Shi-Qi Mei, Jia-Qi Liu, Xu-Hui Guan, Yu Deng, Zhi-Hong Chen, Hai-Yan Tu, Chong-Rui Xu, Hua-Jun Chen, Wen-Zhao Zhong, Jin-Ji Yang, Xu-Chao Zhang, Tony S K Mok, Yi-Long Wu, Qing Zh |
A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion-positive non-small cell lung cancer. Cancer 2023 10 . Bianca A M H van Veggel, Anthonie J van der Wekken, Marthe S Paats, Lizza E L Hendriks, Sayed M S Hashemi, Antonios Daletzakis, Daan van den Broek, Linda J W Bosch, Kim Monkhorst, Egbert F Smit, Adrianus J de Lang |
A study of gene variation in All-RAS wild-type metastatic colorectal cancer and its correlation with cetuximab. Journal of gastrointestinal oncology 2023 1 13 (6): 3009-3024. Tao Huimin, Shen Meng, Zhang Xiaochang, Wang Minghui, Wu Yan, Sun Hui, Ling Chen, Yang Ying, Chen Kai, Li Dape |
Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer. Cancer discovery 2024 4 OF1-OF12. Rona Yaeger, Nataliya V Uboha, Meredith S Pelster, Tanios S Bekaii-Saab, Minal Barve, Joel Saltzman, Joshua K Sabari, Julio A Peguero, Andrew Scott Paulson, Pasi A Jänne, Marcia Cruz-Correa, Kenna Anderes, Karen Velastegui, Xiaohong Yan, Hirak Der-Torossian, Samuel J Klempner, Scott E Kope |
Gene signatures derived from transcriptomic-causal networks stratified colorectal cancer patients for effective targeted therapy. Research square 2024 1 . Akram Yazdani, Heinz-Josef Lenz, Gianluigi Pillonetto, Raul Mendez-Giraldez, Azam Yazdani, Hanna Sanof, Reza Hadi, Esmat Samiei, Alan P Venook, Mark J Ratain, Naim Rashid, Benjamin G Vincent, Xueping Qu, Yujia Wen, Michael Kosorok, William F Symmans, John Paul Y C Shen, Michael S Lee, Scott Kopetz, Andrew B Nixon, Monica M Bertagnolli, Charles M Perou, Federico Innocen |
Triplet chemotherapy plus cetuximab as first-line treatment in extended RAS wild-type metastatic colorectal cancer patients. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2024 1 . Emmanuelle Samalin, Thibault Mazard, Eric Assenat, Magali Rouyer, Christelle de la Fouchardière, Rosine Guimbaud, Denis Smith, Fabienne Portales, Marc Ychou, Antoine Adenis, Catherine Fiess, Evelyne Lopez-Crapez, Simon Thezen |
CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value. Journal for immunotherapy of cancer 2024 1 12 (1): . Francesca Battaglin, Yasmine Baca, Joshua Millstein, Yan Yang, Joanne Xiu, Hiroyuki Arai, Jingyuan Wang, Fang-Shu Ou, Federico Innocenti, Shannon M Mumenthaler, Priya Jayachandran, Natsuko Kawanishi, Annika Lenz, Shivani Soni, Sandra Algaze, Wu Zhang, Taline Khoukaz, Evanthia Roussos Torres, Andreas Seeber, Jim P Abraham, Emil Lou, Philip A Philip, Benjamin A Weinberg, Anthony F Shields, Richard M Goldberg, John L Marshall, Alan P Venook, W Michael Korn, Heinz-Josef Le |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: